Therefore, these equations cannot be used in patients with exogenous insulin use ( Despite important knowledge gaps in our understanding of IR in T1D, targeting IR in overweight/obese patients with T1D may decrease the risk of diabetes complications, contribute to weight loss, and improve glycemic control
And, in a meta analysis looking at the use of berberine in women with polycystic ovarian syndrome (PCOS), it was found that berberine may: Reduce visceral fat mass Improve ovulation rate Alter fat distribution However, in the majority of these studies, dietary and lifestyle changes were implemented alongside berberine use
Semaglutide: A Versatile Player Sema glutide has emerged as a dynamic contributor among GLP-1 agonists, receiving FDA approval for its role in managing type 2 diabetes, combating chronic kidney disease and aiding weight loss
Bestaan er Ozempic tabletten